Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-057009
Filing Date
2007-03-16
Accepted
2007-03-16 15:26:50
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006 d10k.htm 10-K 830491
2 AGREEMENT AND PLAN OF MERGER dex21.htm EX-2.1 451545
3 FOURTH AMENDMENT TO THE 2000 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN dex1027.htm EX-10.27 5916
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 839
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1828
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER (302) dex311.htm EX-31.1 9921
7 CERTIFICATION OF VICE PRESIDENT OF FINANCE (302) dex312.htm EX-31.2 9929
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER (906) dex32.htm EX-32 5537
  Complete submission text file 0001193125-07-057009.txt   1317273
Mailing Address
Business Address 10301 STELLA LINK HOUSTON TX 77025 7136642288
TANOX INC (Filer) CIK: 0001099414 (see all company filings)

EIN.: 760196733 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30231 | Film No.: 07699939
SIC: 2834 Pharmaceutical Preparations